These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 2971675)

  • 1. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
    Takeuchi T; Tanaka S; Steinberg AD; Matsuyama T; Daley J; Schlossman SF; Morimoto C
    J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen.
    Takeuchi T; Rudd CE; Schlossman SF; Morimoto C
    Eur J Immunol; 1987 Jan; 17(1):97-103. PubMed ID: 2949986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.
    Morimoto C; Steinberg AD; Letvin NL; Hagan M; Takeuchi T; Daley J; Levine H; Schlossman SF
    J Clin Invest; 1987 Mar; 79(3):762-8. PubMed ID: 2950134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects of autologous mixed lymphocyte reaction-activated immunoregulatory T cells in patients with systemic lupus erythematosus.
    Koide J; Takeuchi T; Hosono O; Takano M; Abe T
    Scand J Immunol; 1987 Oct; 26(4):363-9. PubMed ID: 2961048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
    Smolen JS; Siminovitch K; Luger TA; Steinberg AD
    Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The isolation and characterization of the human suppressor inducer T cell subset.
    Morimoto C; Letvin NL; Distaso JA; Aldrich WR; Schlossman SF
    J Immunol; 1985 Mar; 134(3):1508-15. PubMed ID: 3155770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus.
    Tanaka S; Matsuyama T; Steinberg AD; Schlossman SF; Morimoto C
    Arthritis Rheum; 1989 Apr; 32(4):398-405. PubMed ID: 2523219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases.
    Morimoto C; Romain PL; Fox DA; Anderson P; DiMaggio M; Levine H; Schlossman SF
    Am J Med; 1988 May; 84(5):817-25. PubMed ID: 2966579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system.
    Takeuchi T; Schlossman SF; Morimoto C
    Cell Immunol; 1987 Jun; 107(1):107-14. PubMed ID: 2953440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
    Volk HD; Diamantstein T
    Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen.
    Takeuchi T; Rudd CE; Tedder TF; Schlossman SF; Morimoto C
    Cell Immunol; 1989 Jan; 118(1):68-84. PubMed ID: 2463098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the T4+2H4+ cell of peripheral blood lymphocyte in systemic lupus erythematosus].
    Jiang M; Sun HY; Zu LP
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):426-8, 457. PubMed ID: 1684317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The isolation and characterization of the human helper inducer T cell subset.
    Morimoto C; Letvin NL; Boyd AW; Hagan M; Brown HM; Kornacki MM; Schlossman SF
    J Immunol; 1985 Jun; 134(6):3762-9. PubMed ID: 3157750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells.
    Stohl W; Crow MK; Kunkel HG
    N Engl J Med; 1985 Jun; 312(26):1671-8. PubMed ID: 2582253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The T4 molecule differentially regulating the activation of subpopulations of T4+ cells.
    Takeuchi T; Schlossman SF; Morimoto C
    J Immunol; 1987 Aug; 139(3):665-71. PubMed ID: 2955047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.
    Morimoto C; Hafler DA; Weiner HL; Letvin NL; Hagan M; Daley J; Schlossman SF
    N Engl J Med; 1987 Jan; 316(2):67-72. PubMed ID: 2946956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the 2H4 molecule in the activation of suppressor inducer function.
    Morimoto C; Matsuyama T; Rudd CE; Forsgren A; Letvin NL; Schlossman SF
    Eur J Immunol; 1988 May; 18(5):731-7. PubMed ID: 2967762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct demonstration of immunoregulatory T-cell defects in patients with systemic lupus erythematosus.
    Koide J; Takano M; Takeuchi T; Hosono O; Amano K; Homma M; Abe T
    Scand J Immunol; 1986 Apr; 23(4):449-59. PubMed ID: 2939553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.
    Morimoto C; Reinherz EL; Distaso JA; Steinberg AD; Schlossman SF
    J Clin Invest; 1984 Mar; 73(3):689-700. PubMed ID: 6231307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.